Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
As of today, Eli Lilly(LLY) shares are valued at $1,229.23. The company's market cap stands at 1.13T, with a P/E ratio of 43.70 and a dividend yield of 0.53%.
During the trading session on 2026-07-07, Eli Lilly(LLY) shares reached a daily high of $1,229.23 and a low of $1,216.00. At a current price of $1,229.23, the stock is +1.1% higher than the low and still 0.0% under the high.
Trading volume for Eli Lilly(LLY) stock has reached 26K, versus its average volume of 3.55M.
The stock's 52-week range extends from a low of $623.78 to a high of $1,238.00.
The stock's 52-week range extends from a low of $623.78 to a high of $1,238.00.
LLY News
Key Points The obesity drug industry is likely a decade-long tailwind for Eli Lilly's business. Foundayo and Retatrutide could cement a decade of growth. The...
...
Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new invest...
Analyst ratings
84%
of 31 ratingsMore LLY News
JPMorgan raised the firm’s price target on Eli Lilly (LLY) to $1,400 from $1,300 and keeps an Overweight rating on the shares. The firm sees potential upside fo...
This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herei...
The latest move in Eli Lilly (LLY) stock comes as the Medicare GLP-1 Bridge program opens wider access to its weight management drugs, alongside strong reported...
Key Points Eli Lilly and dominance in weight loss and diabetes treatments continues to fuel massive revenue growth. Teva Pharmaceutical Industries offers a va...
Key Points Eli Lilly is the leader in the GLP-1 drug market. This leadership has supercharged earnings growth and stock performance in recent years. 10 stock...
(RTTNews) - DKSH Holding AG (DKSH.SW, DKSH), a Swiss market expansion services provider, on Monday has entered into a distribution and promotion agreement with...
In late June 2026, Eli Lilly reported strong Q1 results, advanced its obesity and diabetes franchise with Medicare’s GLP‑1 Bridge program, and gained a positive...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.